Paper32256192
Molecular and Cellular Pathways Contributing to Joint Damage in Rheumatoid Arthritis.
Fang Q and 2 others. Mediators Inflamm, 2020. Cited by 173 papers, by iCite.
Cite this record
ConductScience Library. Molecular and Cellular Pathways Contributing to Joint Damage in Rheumatoid Arthritis. Papers, record 32256192. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32256192
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arthritis, Rheumatoid | Major topic |
| Osteoclasts | Major topic |
| Animals | |
| Autoantibodies | |
| Chemokines | |
| Chondrocytes | |
| Fibroblasts | |
| Humans |
Source PubMed
References72
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27046227 | Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis. | Nat Commun | 2016 | https://conductscience.org/library/papers/27046227 | PubMed |
| 2 | 26613766 | Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism. | Ann Rheum Dis | 2016 | https://conductscience.org/library/papers/26613766 | PubMed |
| 3 | 29702364 | Mechanisms and therapeutic targets for bone damage in rheumatoid arthritis, in particular the RANK-RANKL system. | Curr Opin Pharmacol | 2018 | https://conductscience.org/library/papers/29702364 | PubMed |
| 4 | 19098927 | The role of ADAMTS-7 and ADAMTS-12 in the pathogenesis of arthritis. | Nat Clin Pract Rheumatol | 2009 | https://conductscience.org/library/papers/19098927 | PubMed |
| 5 | 23983153 | Association of genetic variants in the IL4 and IL4R genes with the severity of joint damage in rheumatoid arthritis: a study in seven cohorts. | Arthritis Rheum | 2013 | https://conductscience.org/library/papers/23983153 | PubMed |
| 6 | 31005898 | Pathogenic effector functions of ACPA: Where do we stand? | Ann Rheum Dis | 2019 | https://conductscience.org/library/papers/31005898 | PubMed |
| 7 | 16476768 | Human antibodies induce arthritis in mice deficient in the low-affinity inhibitory IgG receptor Fc gamma RIIB. | J Exp Med | 2006 | https://conductscience.org/library/papers/16476768 | PubMed |
| 8 | 29740441 | Targeting B Cells and Plasma Cells in Autoimmune Diseases. | Front Immunol | 2018 | https://conductscience.org/library/papers/29740441 | PubMed |
| 9 | 30589082 | Dendritic cells, T cells and their interaction in rheumatoid arthritis. | Clin Exp Immunol | 2019 | https://conductscience.org/library/papers/30589082 | PubMed |
| 10 | 20193003 | Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. | Immunol Rev | 2010 | https://conductscience.org/library/papers/20193003 | PubMed |
| 11 | 31123462 | C-Cbl negatively regulates TRAF6-mediated NF-κB activation by promoting K48-linked polyubiquitination of TRAF6. | Cell Mol Biol Lett | 2019 | https://conductscience.org/library/papers/31123462 | PubMed |
| 12 | 26065586 | Antibody-independent functions of B cells: a focus on cytokines. | Nat Rev Immunol | 2015 | https://conductscience.org/library/papers/26065586 | PubMed |
| 13 | 26656659 | Cytokines in rheumatoid arthritis - shaping the immunological landscape. | Nat Rev Rheumatol | 2016 | https://conductscience.org/library/papers/26656659 | PubMed |
| 14 | 27807193 | PTPN22 Is a Critical Regulator of Fcγ Receptor-Mediated Neutrophil Activation. | J Immunol | 2016 | https://conductscience.org/library/papers/27807193 | PubMed |
| 15 | 21203996 | The role of ADAMTSs in arthritis. | Protein Cell | 2010 | https://conductscience.org/library/papers/21203996 | PubMed |
| 16 | 31196979 | Cartilage-binding antibodies induce pain through immune complex-mediated activation of neurons. | J Exp Med | 2019 | https://conductscience.org/library/papers/31196979 | PubMed |
| 17 | 23024017 | Osteoclast migration, differentiation and function: novel therapeutic targets for rheumatic diseases. | Rheumatology (Oxford) | 2013 | https://conductscience.org/library/papers/23024017 | PubMed |
| 18 | 30709614 | Neutrophils in Rheumatoid Arthritis: Breaking Immune Tolerance and Fueling Disease. | Trends Mol Med | 2019 | https://conductscience.org/library/papers/30709614 | PubMed |
| 19 | 11435459 | c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. | J Clin Invest | 2001 | https://conductscience.org/library/papers/11435459 | PubMed |
| 20 | 22505457 | Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. | J Clin Invest | 2012 | https://conductscience.org/library/papers/22505457 | PubMed |
Cited by114
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 173 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42936105 | Programmed cell death: immune regulatory mechanisms in periodontitis and rheumatoid arthritis. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42936105 | PubMed |
| 42780125 | Astilbin: a novel therapeutic strategy for bone destruction in rheumatoid arthritis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42780125 | PubMed |
| 42553716 | Research Progress on Self-Assembling Delivery Systems in Rheumatoid Arthritis. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42553716 | PubMed |
| 42393478 | Therapeutic evaluation of myricetin in experimental arthritis: modulation of inflammatory signaling and oxidative stress pathways. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/42393478 | PubMed |
| 42052934 | Identification of Anti-Inflammatory and Analgesic Mechanisms of Naru-3 Wei Pill Using Animal Models, UHPLC-QE-MS, and Integrated Network Pharmacology. | Mediators Inflamm | 2026 | https://conductscience.org/library/papers/42052934 | PubMed |
| 42042060 | Molecular Analysis of miR-155 and MIR155HG Mutations in Conjunction with TLR4 Variants in Inflammatory Joint Disease. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42042060 | PubMed |
| 41784928 | Therapeutic efficacy of Curcuma longa leaf extract in experimental models of arthritis. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/41784928 | PubMed |
| 41653212 | Extracellular matrix remodeling in the pathogenesis and therapeutic strategies of rheumatoid arthritis. | Clin Exp Med | 2026 | https://conductscience.org/library/papers/41653212 | PubMed |
| 41540163 | New Paradigm for Rheumatoid Arthritis Treatment: A Review of 'Crosstalk' Mechanism of Multi-Targeted Intervention on Cytokine/Chemokine Networks by Chinese Medicine. | Chin J Integr Med | 2026 | https://conductscience.org/library/papers/41540163 | PubMed |
| 41451227 | The immunoregulatory role of integrins in pulmonary diseases. | Front Immunol | 2025 | https://conductscience.org/library/papers/41451227 | PubMed |
| 41192416 | Mesothelin as a biomarker and potential therapeutic target in rheumatoid arthritis bone destruction. | Cell Rep Med | 2025 | https://conductscience.org/library/papers/41192416 | PubMed |
| 41156657 | A Review of the Biology of Chikungunya Virus Highlighting the Development of Current Novel Therapeutic and Prevention Approaches. | Pathogens | 2025 | https://conductscience.org/library/papers/41156657 | PubMed |
| 41105344 | Dual evaluation of Citrullus colocynthis fruit extract for anti-rheumatic activity: integrating in silico docking and in vivo murine RA model analysis. | Inflammopharmacology | 2025 | https://conductscience.org/library/papers/41105344 | PubMed |
| 41079378 | Up-regulation of SELENBP1 in inflammatory macrophages promoted proliferation and migration of synovial fibroblasts by promoting ROS production via blocking NRF2 signaling in rheumatoid arthritis. | Cent Eur J Immunol | 2025 | https://conductscience.org/library/papers/41079378 | PubMed |
| 41012455 | Advances in Intra-Articular Injection Hydrogel Drug Delivery Systems in the Treatment of Rheumatoid Arthritis. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41012455 | PubMed |
| 40978541 | Synthesis, characterization and in vitro evaluation of ticagrelor and its nano-formulation targeting the NLRP3 inflammasome pathway in synovial cells. | Nanoscale Adv | 2025 | https://conductscience.org/library/papers/40978541 | PubMed |
| 40822459 | Soufeng sanjie formula alleviates bone erosion in CIA mice via inhibiting RANKL/NF-κB signaling pathway and ameliorates the RA symptom in patients. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40822459 | PubMed |
| 40707975 | Targeting rheumatoid arthritis: a molecular perspective on biologic therapies and clinical progress. | J Biol Eng | 2025 | https://conductscience.org/library/papers/40707975 | PubMed |
| 40679780 | From Homeostasis To Inflammation To Autoimmunity: The Potential Impact of CRP. | Inflammation | 2025 | https://conductscience.org/library/papers/40679780 | PubMed |
| 40594998 | Association of DNA damage response pathway genes with rheumatoid arthritis risks: a case-control study. | Sci Rep | 2025 | https://conductscience.org/library/papers/40594998 | PubMed |
Genes173
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32256192
GET https://conductscience.org/api/papers/v1/32256192/references?page=2